Page last updated: 2024-11-06

triethylenemelamine and Ependymoma

triethylenemelamine has been researched along with Ependymoma in 1 studies

Triethylenemelamine: Toxic alkylating agent used in industry; also as antineoplastic and research tool to produce chromosome aberrations and cancers.

Ependymoma: Glioma derived from EPENDYMOGLIAL CELLS that tend to present as malignant intracranial tumors in children and as benign intraspinal neoplasms in adults. It may arise from any level of the ventricular system or central canal of the spinal cord. Intracranial ependymomas most frequently originate in the FOURTH VENTRICLE and histologically are densely cellular tumors which may contain ependymal tubules and perivascular pseudorosettes. Spinal ependymomas are usually benign papillary or myxopapillary tumors. (From DeVita et al., Principles and Practice of Oncology, 5th ed, p2018; Escourolle et al., Manual of Basic Neuropathology, 2nd ed, pp28-9)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Crue, BL1
Todd, EM1
Lockwood, RW1

Other Studies

1 other study available for triethylenemelamine and Ependymoma

ArticleYear
II. Medulloblastoma. Therapy with triethylene melamine and cobalt 60 irradiation.
    Bulletin of the Los Angeles neurological societies, 1967, Volume: 32, Issue:3

    Topics: Cerebellar Neoplasms; Cerebellum; Child; Cobalt Isotopes; Culture Techniques; Ependymoma; Glioma; Hu

1967